Session 20
Vaccines II

Programm

• 16:00 – 16:15 10 Min. 5 Min.

  • Abstract Talk
  • AT 18

  Structural studies of dengue virus antibody/antigen complexes

  • Professor Félix A. Rey (Paris / FR)

   Vaccines
• 16:15 – 16:30 10 Min. 5 Min.

  • Abstract Talk
  • AT 53

  Stalk antibody-mediated broad protection against influenza viruses

  • Dr. Nisreen Okba (New York, NY / US)

   Vaccines
• 16:30 – 16:45 10 Min. 5 Min.

  • Abstract Talk
  • AT 54

  Development of an economically viable vaccine for CCHF virus

  • Dr. Mine Aksular (Oxford / GB)

   Immune response to virus infection, Vaccines
• 16:45 – 17:00 10 Min. 5 Min.

  • Abstract Talk
  • AT 55

  Low energy electron irradiation efficiently inactivates various viruses in liquids for vaccine production processes

  • Dr. Jasmin Fertey (Leipzig / DE)

   Vaccines
• 17:00 – 17:15 10 Min. 5 Min.

  • Abstract Talk
  • AT 56

  A novel SARS-CoV-2 modified live vaccine with an optimized safety profile induces sterile immunity in Syrian hamsters

  • Dr. Jacob Schön (Greifswald – Insel Riems / DE)

   SARS -CoV2 and other coronaviruses, Vaccines
• 17:15 – 17:30 10 Min. 5 Min.

  • Abstract Talk
  • AT 57

  Virus-like particle vaccine production in insect cells without contaminating baculovirus particles

  • Linda van Oosten (Wageningen / NL)

   Invertebrate viruses, Vaccines
• 17:30 – 17:45 10 Min. 5 Min.

  • Abstract Talk
  • AT 58

  Developing live attenuated vaccines for SARS-CoV-2

  • Professor Dong-Yan Jin (Pokfulam / HK)

   Vaccines